GregoryRyanSuttonMD
Oncology • Chattanooga, TNTennessee Oncology - Chattanooga and Northwest Georgia locations
Dr. Sutton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2200 E 3rd St
Suite 100
Chattanooga, TN 37404Phone+1 423-698-1844
Summary
- Dr. Gregory Sutton is an oncologist and hematologist in Chattanooga, TN and is affiliated with Parkridge Medical Center, Memorial, and Erlanger hospital systems. He received his medical degree from University of Tennessee Health Science Center College of Medicine and has been in practice 8 years. He is experienced in all solid oncology tumors, amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma. He is also a clinical trial investigator in collaboration with Sarah Canon Research Institution.
Education & Training
University of TennesseeFellowship, Hematology and Medical Oncology, 2012 - 2015
University of Tennessee College of Medicine at ChattanoogaResidency, Internal Medicine, 2009 - 2012
University of Tennessee Health Science Center College of MedicineClass of 2009
Certifications & Licensure
GA State Medical License 2021 - 2026
TN State Medical License 2011 - 2026
AL State Medical License 2020 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients Start of enrollment: 2009 Mar 01
- Chemotherapy in Treating Patients With Sarcoma of the Uterus Start of enrollment: 2000 May 01
- Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsEzatiostat hydrochloride for the treatment of myelodysplastic syndromesDaruka Mahadevan, Gregory Ryan Sutton
Expert Opinion on Investigational Drugs. 2015-04-08 - 32 citationsPhase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with ...Daruka Mahadevan, Gregory Ryan Sutton, Rafael Arteta-Bulos, Chris Bowden, PJ Miller
Cancer Chemotherapy and Pharmacology. 2014-01-04 - 17 citationsGrade and Prognosis in Localized Primary AngiosarcomaManjari Pandey, Gregory R. Sutton, Smith Giri, Michael Gary Martin
Clinical Breast Cancer. 2015-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
